Intrexon Corp Company Profile (NYSE:XON)

About Intrexon Corp

Intrexon Corp logoIntrexon Corporation (Intrexon) forms collaborations to create biologically based products and processes using synthetic biology. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components. The Company's synthetic biology capabilities include the ability to control the amount, location and modification of biological molecules to control the function and output of living cells and optimize for desired results at an industrial scale. Its technologies combine the principles of precision engineering, statistical modeling, automation and production at an industrial scale. The Company's technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabled Analysis and Processing, or LEAP, and ActoBiotics platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: XON
  • CUSIP:
Key Metrics:
  • Previous Close: $21.91
  • 50 Day Moving Average: $22.87
  • 200 Day Moving Average: $26.55
  • 52-Week Range: $118,575,000.00 - $20.39
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -30.01
  • P/E Growth: 0.33
  • Market Cap: $2.60B
  • Outstanding Shares: 118,575,000
  • Beta: 1.5
Profitability:
  • Net Margins: -93.97%
  • Return on Equity: -18.46%
  • Return on Assets: -12.13%
Debt:
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 3.15%
  • Quick Ratio: 2.93%
Additional Links:
Companies Related to Intrexon Corp:

Analyst Ratings

Consensus Ratings for Intrexon Corp (NYSE:XON) (?)
Ratings Breakdown: 3 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $44.43 (102.78% upside)

Analysts' Ratings History for Intrexon Corp (NYSE:XON)
Show:
DateFirmActionRatingPrice TargetDetails
2/3/2017JMP SecuritiesSet Price TargetBuy$42.00View Rating Details
12/29/2016Northland SecuritiesInitiated CoverageOutperform$40.00View Rating Details
11/11/2016J P Morgan Chase & CoReiterated RatingHoldView Rating Details
8/16/2016Griffin SecuritiesReiterated RatingBuy$55.00View Rating Details
7/7/2016WunderlichReiterated RatingBuy$50.00View Rating Details
6/29/2016Stifel NicolausReiterated RatingBuy$57.00View Rating Details
3/3/2016Bank of America CorpReiterated RatingNeutral$41.00 -> $38.00View Rating Details
3/1/2016MizuhoReiterated RatingNeutral$28.00 -> $29.00View Rating Details
8/11/2015Merriman CapitalUpgradeNeutral -> Buy$85.00View Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Intrexon Corp (NYSE:XON)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/1/2017Q416($0.23)$52.53 millionN/AView Earnings Details
11/9/2016Q316($0.21)($0.24)$51.70 million$48.99 millionViewListenView Earnings Details
8/9/2016Q216($0.26)($0.42)$53.78 million$52.50 millionViewN/AView Earnings Details
5/10/2016Q1($0.20)($0.55)$46.26 million$43.40 millionViewListenView Earnings Details
2/29/2016Q415($0.18)($0.28)$41.82 million$41.50 millionViewListenView Earnings Details
11/9/2015Q3($0.21)($0.34)$40.84 million$53.40 millionViewN/AView Earnings Details
8/10/2015Q215($0.04)$0.01$55.93 million$44.90 millionViewListenView Earnings Details
5/11/2015Q115($0.12)$0.25$32.90 million$33.80 millionViewListenView Earnings Details
3/2/2015Q414($0.16)$0.18$26.11 million$31.10 millionViewN/AView Earnings Details
11/13/2014Q314($0.16)($0.53)$19.40 million$21.20 millionViewN/AView Earnings Details
8/14/2014Q214($0.13)($0.11)$9.39 million$11.80 millionViewN/AView Earnings Details
5/7/2014Q1$0.06$0.04$11.25 million$7.90 millionViewN/AView Earnings Details
3/31/2014Q413($0.14)($0.13)$8.38 million$7.10 millionViewN/AView Earnings Details
11/7/2013($0.03)$0.15$9.79 million$6.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intrexon Corp (NYSE:XON)
Current Year EPS Consensus Estimate: $-1.43 EPS
Next Year EPS Consensus Estimate: $-0.73 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.22)($0.21)($0.22)
Q2 20162($0.22)($0.21)($0.22)
Q3 20162($0.26)($0.22)($0.24)
Q4 20162($0.24)($0.18)($0.21)
Q1 20171($0.22)($0.22)($0.22)
Q2 20171($0.20)($0.20)($0.20)
Q3 20171($0.22)($0.22)($0.22)
Q4 20171($0.20)($0.20)($0.20)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intrexon Corp (NYSE:XON)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intrexon Corp (NYSE:XON)
Insider Ownership Percentage: 55.10%
Institutional Ownership Percentage: 84.51%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/13/2016Randal J KirkCEOBuy34,606$28.90$1,000,113.40View SEC Filing  
12/12/2016Joel D LiffmanSVPBuy8,500$28.62$243,270.00View SEC Filing  
12/1/2016Fred HassanDirectorBuy6,900$29.02$200,238.00View SEC Filing  
8/29/2016Nir NimrodiSVPBuy4,000$26.12$104,480.00View SEC Filing  
5/13/2016Randal J KirkCEOBuy41,830$23.92$1,000,573.60View SEC Filing  
12/11/2015Randal J KirkCEOBuy124,475$29.85$3,715,578.75View SEC Filing  
12/7/2015Randal J KirkCEOBuy237,525$30.69$7,289,642.25View SEC Filing  
12/4/2015Suma KrishnanSVPSell20,900$35.66$745,294.00View SEC Filing  
1/27/2015Randal J KirkCEOBuy555,556$27.00$15,000,012.00View SEC Filing  
5/13/2014Donald LehrInsiderBuy1,850$15.99$29,581.50View SEC Filing  
5/13/2014Randal KirkCEOBuy65,173$15.19$989,977.87View SEC Filing  
5/9/2014Kelly HuangSVPBuy3,200$15.78$50,496.00View SEC Filing  
5/9/2014Krish KrishnanCOOBuy20,900$14.21$296,989.00View SEC Filing  
3/27/2014Randal KirkCEOBuy243,001$25.72$6,249,985.72View SEC Filing  
3/4/2014Gregory Ian FrostSVPBuy100,000$25.95$2,595,000.00View SEC Filing  
8/13/2013Jeffrey B KindlerDirectorBuy33,000$16.00$528,000.00View SEC Filing  
8/13/2013Randal J KirkCEOBuy1,887,500$16.00$30,200,000.00View SEC Filing  
8/13/2013Thomas D ReedInsiderBuy1,800$16.00$28,800.00View SEC Filing  
8/13/2013Thomas R KasserSVPBuy5,000$16.00$80,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Intrexon Corp (NYSE:XON)
DateHeadline
News IconInvestor Arena: Keeping an Eye on Intrexon Corp (XON) - Piedmont Register (NYSE:XON)
piedmontregister.com - February 25 at 4:35 AM
News IconCan We Learn Anything From The Technical Chart of Intrexon Corporation (XON)? - NY Stock News (NYSE:XON)
nystocknews.com - February 25 at 4:35 AM
4-traders.com logoIntrexon : Lt. Gen. Ret. Thomas P. Bostick, Head of Intrexon's Environment Sector, Elected to National Academy of Engineering (NYSE:XON)
www.4-traders.com - February 24 at 12:30 AM
News IconFiscal Year Earnings Estimate on Intrexon Corporation(XON) - Money Flow Index & Trends (NYSE:XON)
www.moneyflowtrends.com - February 23 at 4:00 AM
finance.yahoo.com logoIntrexon to Announce Fourth Quarter and Full Year 2016 Financial Results on March 1st (NYSE:XON)
finance.yahoo.com - February 22 at 10:53 AM
News IconAverage Brokerage Rating Of Intrexon Corporation (XON), Berry Plastics Group, Inc. (BERY) - The USA Commerce (NYSE:XON)
theusacommerce.com - February 19 at 8:03 AM
News IconTrader's Buzzers: Welltower Inc. (NYSE:HCN), Intrexon Corporation (NYSE:XON) - The Newburgh Press (NYSE:XON)
newburghpress.com - February 17 at 5:18 PM
News IconAre Analysts Optimistic About Where Intrexon Corporation (NYSE:XON) is Heading? - Winfield Review (NYSE:XON)
winfieldreview.com - February 17 at 5:18 PM
fool.com logoInvestors Are Betting Big Against Intrexon -- Here's Why They're Right (NYSE:XON)
www.fool.com - February 17 at 5:18 PM
News IconWhy to Keeping Eye on Intrexon Corporation (XON), Plains GP ... - StockNewsJournal (NYSE:XON)
stocknewsjournal.com - February 17 at 8:19 AM
finance.yahoo.com logoGMOs and engineered biology (NYSE:XON)
finance.yahoo.com - February 17 at 8:19 AM
finance.yahoo.com logoZIOPHARM Reports Fourth-Quarter 2016 Financial Results and Provides Update on Recent Activities (NYSE:XON)
finance.yahoo.com - February 17 at 8:19 AM
prnewswire.com logoLt. Gen. (Ret.) Thomas P. Bostick, Head of Intrexon's Environment Sector, Elected to National Academy of Engineering - PR Newswire (press release) (NYSE:XON)
www.prnewswire.com - February 15 at 7:00 AM
finance.yahoo.com logoLt. Gen. (Ret.) Thomas P. Bostick, Head of Intrexon's Environment Sector, Elected to National Academy of Engineering (NYSE:XON)
finance.yahoo.com - February 14 at 7:11 AM
News IconTicker Scope: Watching Shares of Intrexon Corporation (NYSE:XON) - Baldwin Journal (NYSE:XON)
baldwinjournal.com - February 11 at 6:26 AM
News IconAnalyst's Indicator Review for Brinker International, Inc. (EAT), Intrexon Corporation (XON) - The USA Commerce (NYSE:XON)
www.theusacommerce.com - February 10 at 6:46 AM
fool.com logoDid a Case of Buyer's Remorse Send Intrexon Corporation Down 13% in January? - Motley Fool (NYSE:XON)
www.fool.com - February 7 at 5:53 AM
fool.com logoDid a Case of Buyer's Remorse Send Intrexon Corporation Down 13% in January? (NYSE:XON)
www.fool.com - February 6 at 1:30 PM
News IconIntrexon Corp XON Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NYSE:XON)
www.bioportfolio.com - February 5 at 5:34 AM
us.rd.yahoo.com logoBill Miller: Apple's cheap but this 'arctic apple' stock ... (NYSE:XON)
us.rd.yahoo.com - February 3 at 6:52 AM
businesswire.com logoSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of GenVec, Inc. And Encourages Investors To Contact The Firm For Additional Information (NYSE:XON)
www.businesswire.com - February 2 at 6:57 AM
fool.com logo3 Strong Reasons to Sell Intrexon (NYSE:XON)
www.fool.com - February 1 at 7:32 AM
4-traders.com logoZIOPHARM Oncology : Utilizing Non-Viral Sleeping Beauty Platform to Rapidly Produce CAR-Expressing T cells Advancing "Point-of-Care" Approach (NYSE:XON)
www.4-traders.com - January 31 at 8:13 AM
News IconWhat’s Next for Intrexon Corp (XON) After Making 52 Week Low? (NYSE:XON)
randolphguide.com - January 31 at 8:13 AM
finance.yahoo.com logoZIOPHARM Utilizing Non-Viral Sleeping Beauty Platform to Rapidly Produce CAR-Expressing T cells Advancing “Point-of-Care” Approach (NYSE:XON)
finance.yahoo.com - January 31 at 8:13 AM
News IconExemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sickle Cell Disease (NYSE:XON)
www.pharmiweb.com - January 29 at 6:47 AM
News IconEquitec Proprietary Markets LLC Holding in Intrexon Corp (Put) (XON) Has Decreased by $4.50 Million - The Randolph Guide (NYSE:XON)
randolphguide.com - January 27 at 9:37 PM
News IconBack to the drawing board? Stock touches new low: Intrexon Corporation (NYSE:XON) - Wall Street Beacon (NYSE:XON)
wsbeacon.com - January 27 at 4:15 PM
News IconEarnings in Full Force, Analysts Take Aim at Intrexon Corporation (NYSE:XON) - Wall Street Beacon (NYSE:XON)
wsbeacon.com - January 27 at 6:52 AM
News IconBack to the drawing board? Stock touches new low: Intrexon ... - Wall Street Beacon (NYSE:XON)
wsbeacon.com - January 27 at 6:52 AM
marketexclusive.com logoINTREXON CORPORATION (NYSE:XON) Files An 8-K Other Events - Market Exclusive (NYSE:XON)
marketexclusive.com - January 27 at 6:52 AM
biz.yahoo.com logoINTREXON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NYSE:XON)
biz.yahoo.com - January 24 at 8:59 PM
News IconIntrexon Corporation (NYSE:XON) Quarterly EPS Projection At $-0.23 - Stock Observer (NYSE:XON)
www.thestockobserver.com - January 24 at 3:57 PM
News IconAre Analysts Predicting a Near-Term Upswing For Intrexon Corporation (NYSE:XON)? - Wall Street Beacon (NYSE:XON)
wsbeacon.com - January 24 at 3:57 PM
nasdaq.com logoMid-Day Market Update: Genvec Jumps Following Announcement of Acquisition By Intrexon; BT Group Shares Drop - Nasdaq (NYSE:XON)
www.nasdaq.com - January 24 at 3:57 PM
News IconIntrexon Corp (NYSE:XON) Stock Worth Watching - Live Trading News (NYSE:XON)
www.livetradingnews.com - January 24 at 3:57 PM
bizjournals.com logoIntrexon to acquire fellow Md. biotech - Baltimore Business Journal (NYSE:XON)
www.bizjournals.com - January 24 at 3:57 PM
finance.yahoo.com logoIntrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform (NYSE:XON)
finance.yahoo.com - January 24 at 3:57 PM
bizjournals.com logoIntrexon to acquire fellow Md. biotech (NYSE:XON)
www.bizjournals.com - January 24 at 3:57 PM
News IconFollowing the Average True Range Indicator for Intrexon Corp (XON) - Springdale Times (NYSE:XON)
springdaletimes.com - January 24 at 5:05 AM
seekingalpha.com logoProject launched in India to evaluate Oxitec's engineered mosquitoes - Seeking Alpha (NYSE:XON)
seekingalpha.com - January 24 at 5:05 AM
finance.yahoo.com logoOxitec and GBIT Announce Launch of Friendly™ Aedes Project in India (NYSE:XON)
finance.yahoo.com - January 24 at 5:05 AM
News IconNon-browning apple coming to U.S. next month but Canada will have to wait (NYSE:XON)
www.cbc.ca - January 23 at 2:08 AM
News IconGM salmon producer AquaBounty completes NASDAQ listing (NYSE:XON)
www.poandpo.com - January 21 at 5:52 AM
morningstar.co.uk logoAquaBounty Completes NASDAQ Listing After US SEC Approval (ALLISS) (NYSE:XON)
www.morningstar.co.uk - January 19 at 4:31 PM
News IconAquabounty completes Nasdaq listing, fundraising (NYSE:XON)
www.undercurrentnews.com - January 19 at 8:07 AM
finance.yahoo.com logoAquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon (NYSE:XON)
finance.yahoo.com - January 19 at 8:07 AM
News IconEPS Of Intrexon Corporation (NYSE:XON) At $-0.23 - Stock Observer (NYSE:XON)
www.thestockobserver.com - January 18 at 6:12 AM
News IconGearing Up For a Bull Run? Analysts Weigh in on Intrexon Corporation (NYSE:XON) - Wall Street Beacon (NYSE:XON)
wsbeacon.com - January 18 at 6:12 AM
realistinvestor.com logoIntrexon Corporation (NYSE:XON) EPS Estimate At $-0.19 - RealistInvestor.com (NYSE:XON)
www.realistinvestor.com - January 13 at 3:28 PM

Social

What is Intrexon Corp's stock symbol?

Intrexon Corp trades on the New York Stock Exchange (NYSE) under the ticker symbol "XON."

Where is Intrexon Corp's stock going? Where will Intrexon Corp's stock price be in 2017?

8 brokers have issued 12-month target prices for Intrexon Corp's shares. Their forecasts range from $29.00 to $57.00. On average, they anticipate Intrexon Corp's share price to reach $44.43 in the next year.

When will Intrexon Corp announce their earnings?

Intrexon Corp is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.

Who owns Intrexon Corp stock?

Intrexon Corp's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Third Security LLC (52.43%), FMR LLC (5.45%), Iridian Asset Management LLC CT (3.17%), State Street Corp (1.70%), Frontier Capital Management Co. LLC (0.52%) and Michael & Susan Dell Foundation (0.37%). Company insiders that own Intrexon Corp stock include Fred Hassan, Joel D Liffman, Nir Nimrodi, Randal J Kirk and Suma Krishnan.

Who sold Intrexon Corp stock? Who is selling Intrexon Corp stock?

Intrexon Corp's stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, FMR LLC, State Street Corp, Iridian Asset Management LLC CT, Brown Advisory Inc., Guggenheim Capital LLC, Palo Alto Investors LLC and Private Advisor Group LLC.

Who bought Intrexon Corp stock? Who is buying Intrexon Corp stock?

Intrexon Corp's stock was bought by a variety of institutional investors in the last quarter, including Third Security LLC, Frontier Capital Management Co. LLC, Michael & Susan Dell Foundation, Clough Capital Partners L P, Dimensional Fund Advisors LP, A.R.T. Advisors LLC, Seven Eight Capital LP and Pacad Investment Ltd.. Company insiders that have bought Intrexon Corp stock in the last two years include Fred Hassan, Joel D Liffman, Nir Nimrodi and Randal J Kirk.

How do I buy Intrexon Corp stock?

Shares of Intrexon Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Intrexon Corp stock cost?

One share of Intrexon Corp stock can currently be purchased for approximately $21.91.

Intrexon Corp (NYSE:XON) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Intrexon Corp (NYSE:XON)

Earnings History Chart

Earnings by Quarter for Intrexon Corp (NYSE:XON)

Dividend History Chart

Dividend Payments by Quarter for Intrexon Corp (NYSE:XON)

Last Updated on 2/27/2017 by MarketBeat.com Staff